There are indications that sensitivity to EGFR antibodies among patients with wild-type K-Ras is positively associated with the mRNA expression of the EGFR ligands epiregulin and amphiregulin in tumor samples [219,252]. The gene discussed is EGFR; the disease is neoplasm.